Semasize Plus 1.7 mg Injection | Semaglutide Weight Loss Exporter India — Ernest Impex

Semasize Plus 1.7 mg Injection: Advanced Weight Management & Cardiovascular Support

Are you looking for a reputable Semasize Plus 1.7 mg Injection exporter from India? Ernest Impex, an integral part of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global distributor specializing in high-potency GLP-1 receptor agonists. We provide robust cold-chain logistics and wholesale pharmaceutical supply to Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica).

Extensive Product Profile: Understanding Semasize Plus 1.7 mg

Semasize Plus 1.7 mg Injection, manufactured by Alkem Laboratories Ltd., is a highly effective subcutaneous therapy containing Semaglutide. This 1.7 mg strength is a critical maintenance dose within the titration schedule, specifically formulated for patients who have surpassed the initial 0.25 mg, 0.5 mg, and 1 mg stages. It bridges the gap toward maximum maintenance, providing significant biological signaling for weight reduction and metabolic health.

1. Clinical Indications & Usage

Chronic Weight Management: Approved for adults and pediatric patients (aged 12 and older) with obesity ($BMI ge 30 kg/m^2$) or overweight ($BMI ge 27 kg/m^2$) who have weight-related comorbidities like hypertension or dyslipidemia.

Cardiovascular Risk Reduction: Clinically utilized to lower the risk of major adverse cardiovascular events (MACE), including non-fatal heart attack, stroke, or cardiovascular death in patients with established heart disease.

Type 2 Diabetes Control: Assists in achieving target HbA1c levels by improving glycemic response.

Metabolic Maintenance: Serves as a long-term dosage to prevent weight regain and maintain insulin sensitivity.

2. Mechanism of Action: The GLP-1 Pathway

Satiety and Appetite Control: It targets the hunger centers of the brain to increase feelings of fullness and decrease cravings, helping patients adhere to reduced-calorie diets.

Glucoregulatory Dynamics: It enhances insulin secretion from the pancreas when blood sugar is high and suppresses the liver's release of stored glucose.

Delayed Gastric Emptying: It slows the movement of food through the digestive tract, leading to a slower rise in blood glucose levels after meals and a prolonged feeling of satiety.

3. Administration and Pack Content

Multi-Dose Pen: One pre-filled pen containing 3 ml of solution ($2.27 mg/ml$).

Complete Accessories: Typically includes 4 sterile needles and 4 alcohol swabs for a once-weekly injection regimen.

Storage, Handling, and Stability Protocols

Primary Cold-Chain: Store unused pens in a refrigerator between 2°C and 8°C.

In-Use Period: Once a pen is in use, it can be kept at controlled room temperature (up to 30°C) or in the refrigerator for up to 56 days.

Light Protection: Always store the pen with the cap on to protect the solution from light.

Safety Critical: Do not freeze. If the medication is accidentally frozen, it becomes inactive and must be discarded.

PRESCRIPTION MEDICINE IS YES

Disclaimer: The information provided is for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any medical or treatment decisions.

📞 Contact Ernest Impex — Pharmaceutical Exporter from India

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]

🌐 Websites:

www.ernestimpex.com

www.ernestvision.com

www.oncologymedicinesupplier.com

www.ernestpharmaceuticals.com

📧 Email: exports@ernestpharmaceuticals.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 93599 02383

📲 WhatsApp Link: https://wa.me/919359902383